The Use of Direct-to-Patient Methods in Decentralized Clinical Trials in Israel
Direct-to-Patient
Clinical trials are essential for advancing medical science and developing new treatments. However, patient recruitment and retention have long been significant challenges in the clinical research process. Direct-to-patient (DtP) approaches seek to address these issues by engaging patients directly in clinical trials, outside the traditional healthcare system. In Israel, a country known for its thriving healthcare and life sciences sector, the adoption of DtP strategies in clinical trials is of particular interest.
Related Education Resources.
All ResourcesFDA Policy for REMS Reqmts during COVID-19
Topics: Health Care, Pharma Industry, Strategic Planning
Guidance Document
Free
Medidata webinar - Evolution of Trial Virtualization & its Impact on Clinical Supplies
Topic: Supply Chain
Webinar
Free
EMA Guidance on Trial Mgmt during COVID-19
Topics: Health Care, Pharma Industry, Strategic Planning
Guidance Document
Free